Law channel feed

As­traZeneca Chi­na ex­ec probed by lo­cal au­thor­i­ties

6 months ago
China

Hun­gary's Olivér Várhe­lyi read­ies to be EU health com­mis­sion­er, pledg­ing ma­jor phar­ma sup­port

7 months ago
Pharma

Sen­a­tors ques­tion whether Pfiz­er, Eli Lil­ly tele­health plat­forms vi­o­late law

7 months ago
Pharma

Am­gen preps to launch Eylea biosim­i­lar years ear­ly af­ter Re­gen­eron los­es ap­peal

7 months ago
Pharma

Lawyers pre­dict Biose­cure pas­sage in lame duck ses­sion, but Sen­ate may de­cide key de­tails

7 months ago
China
Pharma

Lil­ly files more law­suits over sales of copy­cat Zep­bound

7 months ago
Pharma

NJ judge toss­es No­var­tis' IRA law­suit in an­oth­er win for gov­ern­ment

7 months ago
Pharma

FDA won't take ac­tion against GLP-1 com­pounders as it re­thinks tirzepatide short­age

7 months ago
FDA+
Health Tech

Eu­ro­pean Com­mis­sion to work more close­ly with Eu­ro­pean Med­i­cines Agency

7 months ago
FDA+

Am­i­cus stock jumps af­ter res­o­lu­tion of Galafold patent lit­i­ga­tion against Te­va

7 months ago
Pharma

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the draw­ing board’

7 months ago
China
Manufacturing

Sack­lers call opi­oid-re­lat­ed fraud claims 'ut­ter­ly mer­it­less'

7 months ago
Pharma

GSK sues Mod­er­na over mR­NA vac­cine patents, seeks 'rea­son­able roy­al­ty'

7 months ago
Pharma

No­vo Nordisk files 18 law­suits against GLP-1 com­pounders in 44 days

7 months ago
Pharma

Te­va to pay $450M to set­tle al­le­ga­tions of kick­backs and gener­ic drug price-fix­ing

7 months ago
Pharma

Ex­clu­sive Q&A: FDA's prin­ci­pal deputy com­mis­sion­er on tak­ing over for Califf, ad­comms, ac­cel­er­at­ed ap­provals and more

7 months ago
People
FDA+

Ma­jor PBMs call for re­mov­ing three FTC com­mis­sion­ers from in­sulin law­suit

7 months ago
Pharma
Health Tech

Com­pound­ing phar­ma­cy group sues FDA for end­ing Eli Lil­ly's GLP-1 drug short­age

7 months ago
Pharma
Health Tech

No­vo and Vi­a­tris set­tle Ozem­pic patent suit as gener­ic en­try date re­mains un­known

7 months ago
Pharma

Many drug price pro­pos­als from can­di­dates and Con­gress won't have much ef­fect, analy­sis finds

7 months ago
FDA+

Supreme Court de­clines to re­view patent bat­tle over in­hala­tion pow­der Yutrepia

7 months ago
Pharma

Al­ny­lam agrees to drop patent law­suit against Mod­er­na over Covid-19 vac­cine

7 months ago
Pharma

As­traZeneca, Ab­b­Vie, PhRMA lose court bat­tle over Louisiana 340B law

7 months ago
Pharma
FDA+

Up­dat­ed: Sen­a­tors ques­tion FDA and FTC over patent and PBM re­forms

7 months ago
FDA+
First page Previous page 45678910 Next page Last page
A service from the Financial Times